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doi:10.1016/j.ejvsextra.2009.10.001Abstract Introduction: We report a case of combined endovascular and surgical treatment in
a patient with Takayasu’s arteritis-induced bilateral renal artery occlusion.
Report: A 38-year-old women suffering from Takayasu’s arteritis-induced renal artery stenosis
(TARAS) was referred to our centre. The patient also complained of claudication and of symp-
toms related to ostial stenosis of superior mesenteric artery. She was treated with a sequence
of open and endovascular procedures and is now on a 3-year uneventful follow-up.
Discussion: To our knowledge, this is the first case of combined endovascular and surgical
treatment of TARAS performed simultaneously in one operative procedure that has ever been
reported in the literature.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license .The incidence of Takayasu’s arteritis-induced renal artery
stenosis (TARAS) among patients varies from 28% to 75%,
depending on reports.1 We present our experience from
a successful treatment of Takayasu’s disease-related
bilateral renal artery occlusion and mid-term follow-up.jvs.2009.11.005.
r (K. Papazoglou).
r Vascular Surgery. Published byCase study
A 38-year-old woman suffering from hypertension due to
TARAS was referred to our centre. The onset of the
patient’s symptoms consisted of malaise, arthritis and
fatigue, but the patient soon developed symptoms of
arterial obstruction in addition to hypertension resistant to
combined drug therapy. The patient also suffered from
intermittent claudication due to left common iliac artery
(LCIA) stenosis. At the time of referral, the patient was in
a remission phase of the disease being under combinedElsevier Ltd.Open access under CC BY-NC-ND license .
Figure 2 Endovascular treatment successfully excluded the
vein-graft aneurysm.
e8 K. Papazoglou et al.therapy (immunosuppressive agents and corticosteroids).
Digital subtractive angiography (DSA) revealed occlusion of
bilateral renal arteries. Both renal arteries were collater-
alised through lumbar arteries.
Following DSA, we proceeded with an LCIA angioplasty
using a self-expandable stent (9 40 mm) (LUMINEXX,
Bard Inc., Tempe, AZ, USA) and also a failed attempt for
renal artery recanalisation through the aortic lumen. We
then decided to proceed with a scheduled combined (open
surgery and endovascular treatment) of both renal arteries.
We first performed an aorto-renal by-pass of the left renal
artery (LRA) using the saphenous vein as a conduit and then
we continued by performing puncture and distal catheter-
isation of a polar branch of the right renal artery (RRA) and
recanalisation of the occluded RRA with angioplasty and
stenting using a 4 20 mm drug-eluting stent (DES)
(Endeavor, Medtronic, Minneapolis, MN, USA).
The patient had an uneventful follow-up with significant
recess of hypertension and claudication symptoms. A series
of computed tomography angiographies (CTAs) (9 and 20
months postoperatively) revealed progressive dilation of the
veinegraft conduit (maximum diameter: 15.6 mm) and also
an increase in the degree of a pre-existing right common iliac
artery (RCIA) stenosis (Fig. 1). A decision for endovascular
approach was made and so we proceeded with the use of
a 5 50 mm stent graft (VIABAHN Endoprosthesis, W.L. Gore
& Associates Inc., Flagstaff, AZ, USA) which successfully
excluded the veinegraft aneurysm (Fig. 2) and also an RCIA
angioplasty using again a 9 40 mm LUMINEXX stent.
Follow-up CTA (6 months) revealed patent renal arteries
and shrinkage of the aneurysm of the pre-existing by-pass,
but the patient complained of symptoms of chronic bowel
ischaemia (CBI). CTA findings revealed ostial stenosis of
superior mesenteric artery (SMA), which was again success-
fully treated with SMA angioplasty using a 5 20 mm balloon.
The patient is now on a 6-month follow-up following the
last intervention and nearly 3 years since the first combinedFigure 1 CT angiography: dilation of the vein-graft conduit
(maximum diameter: 15,6 mm).procedure, being on a single-agent anti-hypertensive
medical therapy and free of any symptoms related to other
vascular beds.
Discussion
Our experience of endovascular treatment of TARAS is
added to an increasing number of reports of a similar
approach for Takayasu’s arteritis.2 However, until now
there has been no report of a case of bilateral renal artery
occlusion treated simultaneously or of the use of DES in
Takayasu’s arteritis apart from a few reports concerning
coronary vessels.3 There are also some reports of the use of
DES in atherosclerotic renal artery stenosis with results
similar to those of bare metal stents.4
Our choice to perform combined open and endovascular
revascularisation of both renal arteries was based upon the
need to restore blood circulation in both kidneys and to
maintain, if possible, collateral circulation in case of any
acute postoperative adverse event. Our aim was to perform
angioplasty in both renal arteries, but that proved to be
technically unfeasible at least for the left renal. As for the
right renal, since we were not able to achieve orthotopic
recanalisation through the aortic lumen, we successfully
performed retrograde recanalisation. Furthermore, since
Takayasu’s disease has a history of relapse, we were able to
treat the patient each time using endovascular procedures
without adding risks related to open surgery.
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